VYGR
Voyager Therapeutics Inc
2.70$
-4.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,851.9% | -78.3% | +51.6% | -16.7% | -74.5% | +3.1% | -19.7% | +157.0% | +14.7% | -83.1% | +22.1% | – | |
| – | -94.8% | -10.4% | +2,571.6% | -5.4% | +8.5% | -3.9% | -0.6% | +14.5% | -6.5% | -97.2% | – | – | |
| – | – | -79.4% | -113.0% | – | – | – | – | – | – | – | +90.5% | – | |
| – | -5.6% | +6.0% | +33.0% | -12.2% | +17.7% | -11.4% | -0.6% | +14.5% | +0.2% | -31.6% | -10.4% | – | |
| – | +24.0% | -16.0% | +17.9% | -19.5% | +10.1% | +7.2% | +8.9% | -22.9% | +1.5% | +0.5% | -9.0% | – | |
| – | +319.8% | -0.5% | -63.3% | -35.4% | +44.1% | -18.1% | +8.9% | -22.9% | +44.8% | +172.5% | -7.4% | – | |
| – | – | -129.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -119.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +364.4% | -98.3% | +71.4% | +79.2% | +1,258.1% | -93.7% | -59.5% | +453.3% | -89.2% | +55.6% | +42.9% | – | |
| – | – | -120.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -117.3% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.